News Glenmark Pharmaceuticals Limited

Equities

GLENMARK

INE935A01035

Delayed NSE India S.E. Other stock markets 02:20:30 2024-04-16 am EDT			5-day change	1st Jan Change
1,061 ^INR	+1.63%		+1.29%	+24.19%

Apr. 01	Glenmark Pharmaceuticals Limited Announces Board Changes	CI
Mar. 12	Nirma Limited completed the acquisition of 75% stake in Glenmark Life Sciences Limited from Glenmark Pharmaceuticals Limited.	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Glenmark Pharmaceuticals Limited Announces Board Changes	Mar. 31	CI
Nirma Limited completed the acquisition of 75% stake in Glenmark Life Sciences Limited from Glenmark Pharmaceuticals Limited.	Mar. 11	CI
Nomura Adjusts Glenmark Pharmaceuticals’ Price Target to INR909 From INR841, Keeps at Neutral	Feb. 20	MT
Transcript : Glenmark Pharmaceuticals Limited, Q3 2024 Earnings Call, Feb 16, 2024	Feb. 15
Glenmark Pharmaceuticals Ltd. reports Consolidated Revenue of Rs. 29,096 Mn for Q3 FY 2023 24	Feb. 15	AQ
Indian shares set to open higher	Feb. 14	RE
India's Glenmark Pharma posts loss for Q3 as remediation cost weighs	Feb. 14	RE
Glenmark Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 14	CI
Glenmark Pharma, Pfizer Launch Atopic Dermatitis Oral Treatment in India	Jan. 31	MT
Indian shares set to open higher ahead of national budget	Jan. 31	RE
Glenmark and Ichnos take a collaborative leap to accelerate innovation in Cancer Treatment with their alliance 'Ichnos Glenmark Innovation'	Jan. 31	AQ
Glenmark Pharmaceuticals Limited Partners with Pfizer to Launch Abrocitinib in India	Jan. 31	CI
Glenmark, Jiangsu Alphamab Biopharmaceuticals and 3D Medicines announce the signing of a License Agreement for KN035 for Multiple Geographies around the World	Jan. 26	AQ
Alphamab Oncology Unit, 3D Medicines Grants Glenmark Unit License to Commercialize Sarcoma Injectable	Jan. 24	MT
India's Glenmark Life Sciences posts Q3 profit rise; strong orderbook ahead, says CEO	Jan. 23	RE
Glenmark Pharmaceuticals Limited Launches Biosimilar of the Popular Antidiabetic Drug, Liraglutide, for the First Time in India	Jan. 02	CI
Glenmark Pharmaceuticals Introduces Anti-Diabetic Drug Liraglutide in India	Jan. 03	MT
Glenmark Pharmaceuticals : is the first to launch Biosimilar of Popular Anti-Diabetic Drug, Liraglutide, in India	Jan. 03	PU
Transcript : Glenmark Pharmaceuticals Limited, Q2 2024 Earnings Call, Nov 15, 2023	Nov. 14
Glenmark Pharmaceuticals Swings to Loss in Fiscal Q2; Shares Slide 5%	Nov. 14	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Glenmark Pharmaceuticals Limited

Equities

GLENMARK

INE935A01035

Summary

Filters